Security key
74365A309
Protalix BioTherapeutics, Inc. - Common Stock (PLX)
CUSIP: 74365A309
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 11,908,531
- Total 13F value
- $17,628,861
- Share change
- +3,716,423
- Put/Call ratio
- 19%
- SEC-reported price per share
- $1.48
- Number of holders
- 62
- Value change
- +$1,905,095
- Number of buys
- 48
- Number of sells
- 33
- Shares outstanding
- 80,610,558
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
62
Top holders
10
PLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Protalix BioTherapeutics, Inc. SEC filings
Protalix BioTherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74365A309
Recent filing periods:
Ownership snapshot
Top reported holders of PLX - Protalix BioTherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 1.5%
Showing 1-6 of 15 holder rows.
Quick read
RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 1.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Comparable ownership
Top 5
RENAISSANCE TECHNOLOGIES LLC
1.5%
MILLENNIUM MANAGEMENT LLC
1.2%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
1.1%
NORTHERN TRUST CORP
0.85%
MARSHALL WACE, LLP
0.76%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.5%
|
$3,043,720
1,188,953 shares
|
— | 31 Mar 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.2%
|
$2,465,308
963,011 shares
|
— | 31 Mar 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
1.1%
|
$2,198,144
858,650 shares
|
— | 31 Mar 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.85%
|
$1,752,981
684,758 shares
|
— | 31 Mar 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.76%
|
$1,574,618
615,085 shares
|
— | 31 Mar 2025 |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
Company
|
0.6%
|
$1,236,160
482,875 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
62
Shares
11,908,531
Rows available
62
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
63
Q2 2025 holders
62
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend